Professor | Fanghong Luo | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Fanghong Luo
Contact Information	nluofanghong@xmu.edu.cn
Language ability	Chinese, English
Province	Fujian

Upload Avatar (500 x 500)

Name

Fanghong Luo

Contact Information

nluofanghong@xmu.edu.cn

Language ability

Chinese, English

Province

Fujian

University/Lab Affiliation and Title	Xiamen University
Faculty	Medical
Academic Background & Achievements	1993-1998 Bachelor of Medicine: Fujian Medical University 1998-2001 Master of Medicine: Fujian Medical University 2006-2013 Doctor of Science: Xiamen University 2016-2017 Visiting Scholar/Postdoctoral: Mayo Clinic, USA
Work Experience	2001-2003 - Xiamen University Cancer Research Center - Teaching Assistant 2004-2014 - Xiamen University School of Medicine Cancer Research Center - Assistant Professor 2014-present - Xiamen University School of Medicine Cancer Research Center - Associate Professor

University/Lab Affiliation and Title

Xiamen University

Faculty

Medical

Academic Background & Achievements

1993-1998 Bachelor of Medicine: Fujian Medical University
1998-2001 Master of Medicine: Fujian Medical University
2006-2013 Doctor of Science: Xiamen University
2016-2017 Visiting Scholar/Postdoctoral: Mayo Clinic, USA

Work Experience

2001-2003 - Xiamen University Cancer Research Center - Teaching Assistant
2004-2014 - Xiamen University School of Medicine Cancer Research Center - Assistant Professor
2014-present - Xiamen University School of Medicine Cancer Research Center - Associate Professor

Areas of Focus	Tumor Targeted Therapy Monoclonal Antibodies Nanomedicine Photodynamic Therapy NRP-1 and GIPC Proteins
Publications	Methotrexate –Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy, Yang Li, Jinyan Lin, Jinyuan Ma, Liang Song, Huirong Lin, Bowen Tang, Dengyue Chen, Guanghao Su, Shefang Ye, Xuan Zhu, Fanghong Luo, and Zhenqing Hou, 2017 Synectin promotes fibrogenesis by regulating PDGFR isoforms through distinct mechanisms, Drinane MC, Yaqoob U, Yu H, Luo F, Greuter T, Arab JP, Kostallari E, Verma VK, Maiers J, De Assuncao TM, Simons M, Mukhopadhyay D, Kisseleva T, Brenner DA, Urrutia R, Lomberk G, Gao Y, Ligresti G, Tschumperlin DJ, Revzin A, Cao S, Shah VH, 2017 Validation of a dual role of methotrexate-based chitosan nanoparticles in vivo, Hou, ZQ, Lin, JY, Li, YX, Guo, FQ, Yu, F, Wu, HJ, Fan, ZX, Zhi, LL, Luo, FH, 2015 Self-targeted, bacillus-shaped, and controlled-release methotrexate prodrug polymeric nanoparticles for intratumoral administration with improved therapeutic efficacy in tumor-bearing mice, Lin, JY, Li, YX, Li, Y, Cui, F, Yu, F, Wu, HJ, Xie, LY, Luo, FH, Hou, ZQ, Lin, CJ, 2015 Validation of a Janus role of methotrexate-based PEGylated chitosan nanoparticles in vitro, Fanghong Luo, Yang Li, Mengmeng Jia, Fei Cui, Hongjie Wu, Fei Yu, Jinyan Lin, Xiangrui Yang, Zhenqing Hou and Qiqing Zhang, 2014 A monoclonal antibody targeting neuropilin-1 inhibits the adhesion of breast cancer cell MCF7 to fibronectin by suppressing FAK/p130cas signaling pathway, Fanwei Zeng, Fanghong Luo, Sha Lv, Haipeng Zhang, Chang Cao, Xiaoli Chen, Shengyu Wang, Zhe Li, Xianjiang Wang, Xiaofeng Dou, Yujuan Dai, Mingjun He, Yafei Zhang, Haiyan Lv, Jianghua Yan and Yuqiang Chen, 2014 Inhibitory effect of neuropilin-1 monoclonal antibody (NRP-1 MAb) on glioma tumor in mice, Chen L, Miao W, Tang X, Zhang H, Wang S, Luo F, Yan J, 2013 Novel superparamagnetic iron oxide nanoparticles for tumor embolization application: Preparation, characterization and double targeting, Xiaoli Chen, Haiyan Lv, Min Ye, Shengyu Wang, Erru Ni, Fanwei Zeng, Chang Cao, Fanghong Luo, Jianghua Yan, 2012 Monoclonal Antibody against Catalytic Domain of PTP1B, Fanwei Zeng, Erru Ni, Shengyu Wang, Sha Lv, Chang Cao, Haipeng Zhang, Haiyan Lv, Xiaoli Chen, Jianghua Yan, and Fanghong Luo, 2012 Monoclonal Antibody Against NRP1 b1b2, Xiang Li, Fanghong luo, Shengyu Wang, Erru Ni, Xiaoyong Tang, Haiyan Lv, Xiaoli Chen, Lukui Chen, and Jianghua Yan, 2011

Areas of Focus

Tumor Targeted Therapy
Monoclonal Antibodies
Nanomedicine
Photodynamic Therapy
NRP-1 and GIPC Proteins

Publications

Methotrexate –Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy, Yang Li, Jinyan Lin, Jinyuan Ma, Liang Song, Huirong Lin, Bowen Tang, Dengyue Chen, Guanghao Su, Shefang Ye, Xuan Zhu, Fanghong Luo, and Zhenqing Hou, 2017
Synectin promotes fibrogenesis by regulating PDGFR isoforms through distinct mechanisms, Drinane MC, Yaqoob U, Yu H, Luo F, Greuter T, Arab JP, Kostallari E, Verma VK, Maiers J, De Assuncao TM, Simons M, Mukhopadhyay D, Kisseleva T, Brenner DA, Urrutia R, Lomberk G, Gao Y, Ligresti G, Tschumperlin DJ, Revzin A, Cao S, Shah VH, 2017
Validation of a dual role of methotrexate-based chitosan nanoparticles in vivo, Hou, ZQ, Lin, JY, Li, YX, Guo, FQ, Yu, F, Wu, HJ, Fan, ZX, Zhi, LL, Luo, FH, 2015
Self-targeted, bacillus-shaped, and controlled-release methotrexate prodrug polymeric nanoparticles for intratumoral administration with improved therapeutic efficacy in tumor-bearing mice, Lin, JY, Li, YX, Li, Y, Cui, F, Yu, F, Wu, HJ, Xie, LY, Luo, FH, Hou, ZQ, Lin, CJ, 2015
Validation of a Janus role of methotrexate-based PEGylated chitosan nanoparticles in vitro, Fanghong Luo, Yang Li, Mengmeng Jia, Fei Cui, Hongjie Wu, Fei Yu, Jinyan Lin, Xiangrui Yang, Zhenqing Hou and Qiqing Zhang, 2014
A monoclonal antibody targeting neuropilin-1 inhibits the adhesion of breast cancer cell MCF7 to fibronectin by suppressing FAK/p130cas signaling pathway, Fanwei Zeng, Fanghong Luo, Sha Lv, Haipeng Zhang, Chang Cao, Xiaoli Chen, Shengyu Wang, Zhe Li, Xianjiang Wang, Xiaofeng Dou, Yujuan Dai, Mingjun He, Yafei Zhang, Haiyan Lv, Jianghua Yan and Yuqiang Chen, 2014
Inhibitory effect of neuropilin-1 monoclonal antibody (NRP-1 MAb) on glioma tumor in mice, Chen L, Miao W, Tang X, Zhang H, Wang S, Luo F, Yan J, 2013
Novel superparamagnetic iron oxide nanoparticles for tumor embolization application: Preparation, characterization and double targeting, Xiaoli Chen, Haiyan Lv, Min Ye, Shengyu Wang, Erru Ni, Fanwei Zeng, Chang Cao, Fanghong Luo, Jianghua Yan, 2012
Monoclonal Antibody against Catalytic Domain of PTP1B, Fanwei Zeng, Erru Ni, Shengyu Wang, Sha Lv, Chang Cao, Haipeng Zhang, Haiyan Lv, Xiaoli Chen, Jianghua Yan, and Fanghong Luo, 2012
Monoclonal Antibody Against NRP1 b1b2, Xiang Li, Fanghong luo, Shengyu Wang, Erru Ni, Xiaoyong Tang, Haiyan Lv, Xiaoli Chen, Lukui Chen, and Jianghua Yan, 2011

Cancer Therapy Monoclonal Antibodies Nanomedicine Photodynamic Nrp-1 Gipc Vegf Pdgf

Linrong Lu - Zhejiang University

Pengxu Qian - Zhejiang University

H. Wang - Zhejiang University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us